Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
113%(9 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
2
20%
Ph phase_1
8
80%

Phase Distribution

8

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
8(80.0%)
Phase 2Efficacy & side effects
2(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Terminated(2)

Detailed Status

Completed8
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
88.9%
Most Advanced
Phase 2

Trials by Phase

Phase 18 (80.0%)
Phase 22 (20.0%)

Trials by Status

terminated110%
completed880%
withdrawn110%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10